NICOLAU; Claude
Patent Applications and Registrations
Patent applications and USPTO patent grants for NICOLAU; Claude.The latest application filed is for "polyvalent derivatives of emoxypine".
- NICOLAU; Claude - Boston MA
- NICOLAU; Claude - Newton MA
| Patent | Date |
|---|---|
| Polyvalent Derivatives Of Emoxypine App 20220096451 - NICOLAU; Claude ; et al. | 2022-03-31 |
| Cell-based Gene Therapy For Neurodegenerative Diseases App 20220000935 - NICOLAU; Claude ; et al. | 2022-01-06 |
| Inositol-based Immunotherapies App 20210361680 - NICOLAU; Claude ; et al. | 2021-11-25 |
| Tumor Eradication By Inositol-tripyrophosphate App 20170027966 - Nicolau; Claude ; et al. | 2017-02-02 |
| Tumor Eradication By Inositol-tripyrophosphate App 20160120887 - Nicolau; Claude ; et al. | 2016-05-05 |
| Tumor Eradication By Inositol-tripyrophosphate App 20140179635 - Nicolau; Claude ; et al. | 2014-06-26 |
| Cyclitols And Their Derivatives And Their Therapeutic Applications App 20140171394 - Lehn; Jean-Marie ; et al. | 2014-06-19 |
| Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases Grant 8,603,487 - Pfeifer , et al. December 10, 2 | 2013-12-10 |
| Cyclitols And Their Derivatives And Their Therapeutic Applications App 20130190524 - Lehn; Jean-Marie ; et al. | 2013-07-25 |
| Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers Grant 8,409,580 - Tosi , et al. April 2, 2 | 2013-04-02 |
| Nucleic Acid Molecules Encoding Anti-amyloid-beta Antibodies App 20120288896 - Greferath; Ruth ; et al. | 2012-11-15 |
| Methods Of Treating Amyloidosis Comprising The Use Of Anti-amyloid Beta Antibodies App 20120244165 - Greferath; Ruth ; et al. | 2012-09-27 |
| Tumor Eradication By Inositol-tripyrophosphate App 20120094961 - NICOLAU; Claude ; et al. | 2012-04-19 |
| Use Of Inositol-tripyrophosphate In Treating Tumors And Diseases App 20120035137 - Fylaktakidou; Konstantina C. ; et al. | 2012-02-09 |
| Use Of Inositol-tripyrophosphate In Treating Tumors And Diseases App 20120003161 - Nicolau; Claude ; et al. | 2012-01-05 |
| Erythropoletin Complementation Or Replacement App 20110294732 - NICOLAU; Claude ; et al. | 2011-12-01 |
| Monoclonal Antibody App 20110070613 - GREFERATH; RUTH ; et al. | 2011-03-24 |
| Monoclonal antibody App 20100297132 - Greferath; Ruth ; et al. | 2010-11-25 |
| Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers Grant 7,807,171 - Tosi , et al. October 5, 2 | 2010-10-05 |
| Therapeutic vaccine Grant 7,807,175 - Pfeifer , et al. October 5, 2 | 2010-10-05 |
| Monoclonal antibodies that recognize epitopes of amyloid-beta Grant 7,772,375 - Greferath , et al. August 10, 2 | 2010-08-10 |
| Therapeutic vaccine App 20090238840 - Pfeifer; Andrea ; et al. | 2009-09-24 |
| Erythropoietin complementation or replacement App 20080312138 - Nicolau; Claude ; et al. | 2008-12-18 |
| Therapeutic vaccine App 20080267986 - Pfeifer; Andrea ; et al. | 2008-10-30 |
| Cyclitols and Their Derivatives and Their Therapeutic Applications App 20080200437 - Lehn; Jean-Marie ; et al. | 2008-08-21 |
| Monoclonal antibody App 20070166311 - Greferath; Ruth ; et al. | 2007-07-19 |
| Tumor eradication by inositol-tripyrophosphate App 20070135389 - Nicolau; Claude ; et al. | 2007-06-14 |
| Use of inositol-tripyrophosphate in treating tumors and diseases App 20060258626 - Nicolau; Claude ; et al. | 2006-11-16 |
| Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin App 20060241086 - Nicolau; Claude ; et al. | 2006-10-26 |
| Use of inositol-tripyrophosphate in treating tumors and diseases App 20060106000 - Nicolau; Claude ; et al. | 2006-05-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 